论文部分内容阅读
目的分析成都市2010年麻疹减毒活疫苗(Measles Attenuated Live Vaccine,MV)强化免疫活动的预防接种异常反应发生特征,探讨MV强化免疫活动的安全性及减少预防接种异常反应的措施。方法对成都市2010年麻疹减毒活疫苗强化免疫活动的预防接种异常反应的资料进行分析。结果成都市2010年MV强化免疫活动共报告57例预防接种异常反应,发生率为128.9/100万剂次;男性多于女性,0岁组异常反应发生率最高,随年龄增大异常反应发生率逐渐降低;接种后<2 d出现反应的占71.93%;临床损害以过敏性皮疹为主,绝大多数病例预后良好。结论 MV强化免疫活动的预防接种异常反应发生率低,各年龄组儿童在接种MV后<2 d是监测的重点。应加强监测,提高预防接种异常反应的预防和处理水平。
OBJECTIVE: To analyze the characteristics of vaccination anomalous response to Measles Attenuated Live Vaccine (MV) in 2010 in Chengdu, and to explore the safety of immunization with measles immunization and the measures to reduce the abnormal response to vaccination. Methods The data of prevention and treatment of immunization against vaccination against live attenuated measles vaccine in Chengdu in 2010 were analyzed. Results In 2010, a total of 57 cases of vaccination anomalous reactions were reported in Chengdu 2010 MV immunization campaign, with an incidence rate of 128.9 / 1 million doses. More men than women and 0-year-old patients had the highest incidence of abnormal reactions. The incidence of abnormal reactions increased with age Gradually decreased. 71.93% of the patients appeared reaction after <2 d inoculation. The clinical damage was mainly allergic rash, and the prognosis was good in most cases. Conclusions The incidence of abnormal vaccination response to MV-intensive immunization activities is low. Children of all age groups <2 days after MV vaccination are the focus of monitoring. Monitoring should be strengthened to raise the level of prevention and treatment of abnormal responses to vaccination.